OnKure Therapeutics (OKUR) Short-term Investments (2020 - 2026)

OnKure Therapeutics (OKUR) has 5 years of Short-term Investments data on file, last reported at $16.0 million in Q3 2024.

• Quarterly Short-term Investments fell 85.97% year-over-year to $16.0 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $16.0 million (down 85.97% YoY) and the FY2023 annual result came in at $75.3 million, down 7.28% from the prior year.
• Short-term Investments fell to $16.0 million in Q3 2024, from $40.7 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $133.6 million in Q2 2023 to a low of $8.6 million in Q2 2022.
• A 5-year average of $51.4 million and a median of $40.7 million in 2024 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2023 — Short-term Investments surged 1455.61% — and 2024, when it tumbled 85.97%.
• Tracing OKUR's Short-term Investments over 5 years: stood at $23.0 million in 2020, then changed by 0.0% to $23.0 million in 2021, then soared by 253.09% to $81.2 million in 2022, then decreased by 7.28% to $75.3 million in 2023, then slumped by 78.79% to $16.0 million in 2024.
• The last three Short-term Investments figures came in at $16.0 million (Q3 2024), $40.7 million (Q2 2024), and $62.5 million (Q1 2024), per Business Quant data.